[1] Farag EA,Jafrey S,Daraan F,Al-Shamali MHM,Khan FY,Coyle PV .2022 .Dengue epidemiology in Qatar from 2013-2021: A retrospective study. Trop Med and Infect Dis, 7(11) : 329.
[2] Sabir MJ,Al-Saud NBS,Hassan SM .2021 .Dengue and human health: A global scenario of its occurrence, diagnosis and therapeutics. Saudi J Biol Sci, 05(9) : 5074-80.
[3] Deng SQ,Yang X,Wei Y,Chen JT,Wang XJ,Peng HJ .2020 .A review on dengue vaccine development. Vaccines, 8(1) : 1-13.
[4] Wang WH,Urbina AN,Chang MR,Assavalapsakul W,Lu PL,Chen YH .2020 .Dengue hemorrhagic fever-A systemic literature review of current perspectives on pathogenesis, prevention and control. J Microbiol Immunol Infect, 03(6) : 963-78.
[5] Maqsood J .2021 .Dengue fever: The global emerging threat. Isra Med J, 13(4) : 244-5.
[6] Wang WH,Urbina AN,Chang MR,Assavalapsakul W,Lu PL,Chen YH .2020 .Dengue hemorrhagic fever-a systemic literature review of current perspectives on pathogenesis, prevention and control. J of Microbiol, Immunol, 03(6) : 963-78.
[7] Taib NM,Atil A .2023 .Tackling dengue issue need proactive measures: a narrative review of current level of prevention and control of dengue in Malaysia. Arch Epidemiol Pub Health Res, 2(1) : 148-53.
[8] Zhang Y,Guo J,Gao Y,Li S,Pan T,Xu G .2022 .9(1): e12690. Heliyon, : .
[9] Murugesan A,Manoharan M.,Dengue Virus M.,Ennaji MM .2020 .. -12-819400-3, 16 : 00016-8.
[10] Adnyana IMDM,Surya A .2023 .Strategy to control and eradicate dengue hemorrhagic fever vectors in Bali. Int J Public Heal Sci, 12(1) : 22201-202.
[11] Ali F,Chorsiya A,Anjum V,Khasimbi S,Ali AJPR .2021 .A systematic review on phytochemicals for the treatment of dengue. Phtother Res, 35(4) : 1782-816.
[12] Murray NEA,Quam MB,Wilder-Smith A .2013 .Epidemiology of dengue: past, present and future prospects. Clin Epidemiol, 5(1) : 299-309.
[13] Norshidah H,Vignesh R,Lai NS .2021 .Updates on dengue vaccine and antiviral: where are we heading?. Molecules, 26(22) : 6768.
[14] Kularatne SA,Dalugama C .2022 .Dengue infection: Global importance, immunopathology and management. Clin Med, 22(1) : 0791-13.
[15] Rozera R,Verma S,Kumar R,Haque A,Attri A .2019 .Herbal remedies, vaccines and drugs for dengue fever: Emerging prevention and treatment strategies. Asian Pacific Journal of Trop Med, 12(4) : 257113-52.
[16] Raafat N,Blacksell SD,Maude RJ .2019 .A review of dengue diagnostics and implications for surveillance and control. Trans R Soc Trop Med Hyg, 113(11) : 653-60.
[17] Lee K,Hsieh CJ,Lee CT,Liu JW .2017 .Diabetic patients sufering dengue are at risk for development of dengue shock syndrome/severe dengue: Emphasizing the impacts of co-existing comorbidity (ies) and glycemic control on dengue severity. J Microbiol Immunol Infect, 12(1) : 69-78.
[18] Waickman AT,Newell K,Endy TP,Thomas SJ .2022 .Biologics for dengue prevention: up-to-date. Expert Opin Biol Ther, 23(1) : 73-87.
[19] Hussin A,Buckle M,Ammar Y,Mohammadjavad P,Shatrah O,Noorsaadah A .2013 .Study the antiviral activity of some derivatives of tetracycline and non-steroid anti inflammatory drugs towards dengue virus. Trop Biomed, 30(4) : 681-90.
[20] Fayzan M,Abid A,Nawaz S,Akram M,Khan FS,Saeed MM .2022 .Current knowledge and awareness of dengue fever among students of government college university Faisalabad. J Biomed Res Environ Sci, 3(1) : 60-4.
[21] Teh BP,Ahmad NB,Mohamad SB,Tan TYC,Mohd Abd Razak MRB,Afzan AB .2022 .Carica papaya Leaf Juice for Dengue: A Scoping Review. Nutrients, 10(8) : 1584.
[22] Piccini LE,Castilla V,Damonte EB .2022 .Inhibition of dengue virus infection by trifluoperazine. Arch Virol, 167(11) : 2203-12.
[23] Troost B,Smit JM .2020 .Recent advances in antiviral drug development towards dengue virus. Curr Opin Virol, 07 : 9-21.
[24] Mahmud MAF,Mutalip MHA,Lodz NA,Muhammad EN,Yoep N,Hasim MH .2022 .The application of environmental management methods in combating dengue: a systematic review. Int J Environ Health Res, 33(11) : 1148-67.
[25] Waheed Y,Sah R,Muhammad K. .2023 .Recent developments in vaccines for viral diseases. Vaccines, 11(2) : 198.
[26] Srisawat N,Thisyakorn U,Ismail Z,Rafiq K,Gubler DJ K .2022 .8): e0010586. PLoS Negl Trop Dis, 16 : .
[27] Lindsey WT,Olin BR,Hansen RA,Bentley JP,McGraw-Hill Education JP .2020 .Systematic Review and MetaAnalysis. Aparasu RR, 14 : 151.
[28] Moher D,Liberati A,Tetzlaf J,Altman DG .2009 .Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. Ann Intern Med, 151(4) : 200908180-9.
[29] Alonso-Coello P,Schünemann HJ,Moberg J,BrignardelloPetersen R,Akl EA,Davoli M . .. , : .
[30] García-Ariza LL,González-Rivillas N,Díaz-Aguirre CJ,RochaRoa C,Padilla-Sanabria L,Castaño-Osorio JC .2023 .Antiviral activity of an indole-type compound derived from natural products, identified by virtual screening by interaction on dengue virus NS5 protein. Viruses, 15(7) : 1563.
[31] Behrouz S,Kühl N,Klein CD .2023 .N-sulfonyl peptide-hybrids as a new class of dengue virus protease inhibitors. Eur J Med Chem, 251 : 115227.
[32] Feracci M,Eydoux C,Fattorini V,Bello LL,Gaufre P,Selisko B .2023 .-752 targets multiple sites and activities on the dengue virus replication enzyme NS5. Antivir Res, 212 : 105574.
[33] Patil P,Alagarasu K,Chowdhury D,Kakade M,Cherian S,Kaushik S .2022 .In-vitro antiviral activity of Carica papaya formulations against dengue virus type 2 and chikungunya virus. Heliyon, 8(1) : 1-9.
[34] Yenuganti VR,Afroz S,Khan RA,Bharadwaj C,Nabariya DK,Nayak N .2022 .Milk exosomes elicit a potent anti-viral activity against dengue virus. J Nanobiotechnol, 20 : 317.
[35] Renantha RR,Liga AR,Tanugroho CB,Denovian LX,Az SL,Budiyanto Z .2022 .Flavonoids as potential inhibitors of dengue virus 2 (DENV2) envelope protein. J Pharm Pharmacogn Res, 10(10) : 660-75.
[36] Shen TJ,Hanh VT,Nguyen TQ,Jhan MK,Ho MR,Lin CF .2020 .Repurposing the antiemetic metoclopramide as an antiviral against dengue virus infection in neuronal cells. Front Cell Infect Microbiol, 10(1) : 606743.
[37] Kesteleyn B,Bardiot D,Bonfanti JF,De Boeck B,Goethals O,Kaptein SJ .2023 .Discovery of acyl-indole derivatives as panserotype dengue virus NS4B inhibitors. J Med Chem, 66(13) : 8808-21.
[38] Farfan-Morales CN,Cordero-Rivera CD,Osuna-Ramos JF,Monroy-Muñoz IE,De Jesús-González LA,Muñoz-Medina JE .2021 .The antiviral efect of metformin on Zika and dengue virus infection. Sci Rep, 11(1) : 8743.
[39] Wan Y,Wu W,Zhang J,Li L,Wan Y,Tang X .2021 .Tenovin-1 inhibited dengue virus replication through SIRT2. Eur J Pharmacol, 907 : 174264.
[40] Wilson DK,Shyamala G,Paulpandi M,Narayanasamy A,Siram K,Karuppaiah A .2021 .Development and characterization of phytoniosome nano vesicle loaded with aqueous leaf extracts of Justicia adhatoda and Psidium guajoava against dengue virus (DEN-2). J Cluster Sci, 32 : 297-304.
[41] Hitakarun A,Khongwichit S,Wikan N,Roytrakul S,Yoksan S,Rajakam S .2020 .Evaluation of the antiviral activity of orlistat (tetrahydrolipstatin) against dengue virus, Japanese encephalitis virus, Zika virus and chikungunya virus. Sci Rep, 10(1) : 1499.
[42] Ali-Seyed M,Vijayaraghavan K. .2020 .Dengue virus infections and antidengue virus activities of Andrographis paniculata. Asian Pac J Trop Med, 13(2) : 275412-55.
[43] Maryam M,Te KK,Wong FC,Chai TT,Gary K,Gan SC .2020 .Antiviral activity of traditional Chinese medicinal plants Dryopteris crassirhizoma and Morus alba against dengue virus. J Integ Agricult, 3119(19) : 62820-0.
[44] Isa DM,Chin SP,Chong WL,Zain SM,Rahman NA,Lee VS .2019 .Dynamics and binding interactions of peptide inhibitors of dengue virus entry. J Biol Phys, 45(1) : 63-76.
[45] Rothan HA,Abdulrahman AY,Khazali AS,Nor Rashid N,Chong TT,Yusof R .2019 .8): e3196. J Pep Sci, 25 : .
[46] Yang CC,Hu HS,Lin HM,Wu PS,Wu RH,Tian JN .2019 .A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses. Antiviral Res, 172 : 104636.
[47] Pu SY,Xiao F,Schor S,Bekerman E,Zanini F,Barouch-Bentov R .2018 .Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment. Antiviral Res, 05 : 67-75.
[48] Chen HH,Chen CC,Lin YS,Chang PC,Lu ZY,Lin CF .2017 .-12 suppresses dengue virus replication by down-regulation of PI3K/ AKT and GRP78. Antiviral Res, 02 : 158-68.
[49] Yu JS,Wu YH,Tseng CK,Lin CK,Hsu YC,Chen YH .2017 .Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway. Sci Rep, 7 : 45171.
[50] Yu JS,Tseng CK,Lin CK,Hsu YC,Wu YH,Hsieh CL .2016 .Celastrol inhibits dengue virus replication via up-regulating type I interferon and downstream interferon-stimulated responses. Antiviral Res, 11 : 49-57.
[51] Estoppey D,Lee CM,Janoschke M,Lee BH,Wan KF,Dong H .2017 .The natural product cavinafungin selectively interferes with Zika and dengue virus replication by inhibition of the host signal peptidase. Cell Rep, 03(3) : 451-60.
[52] van Cleef KWR,Overheul GJ,Thomassen MC,Marjakangas JM .2016 .Escape mutations in NS4B render Dengue virus insensitive to the antiviral activity of the paracetamol metabolite AM404. Antimicrob Agents Chemother, 60(4) : 15-7.
[53] Bryan-Marrugo OL,Arellanos-Soto D,Rojas-Martinez A,Barrera-Saldaña H,Ramos-Jimenez J,Vidaltamayo R .2016 .The anti-dengue virus properties of statins may be associated with alterations in the cellular antiviral profile expression. Mol Med Rep, 14(3) : 2155-63.
[54] Watanabe S,Chan KWK,Dow G,Ooi EE,Low JG,Vasudevan SG .2015 .Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: The search for a window for potential therapeutic eficacy. Antiviral Res, 12 : 10-9.
[55] Leela SL,Srisawat C,Sreekanth GP,Noisakran S,Yenchitsomanus PT,Limjindaporn T. .2016 .Drug repurposing of minocycline against dengue virus infection. Biochem Biophys Res Commun, 07(1) : 410-6.
[56] Brai A,Fazi R,Tintori C,Zamperini C,Bugli F,Sanguinetti M .2016 .Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents. Proc Natl Acad Sci USA, 113(19) : 5388-93.
[57] Sweeney NL,Hanson AM,Mukherjee S,Ndjomou J,Geiss BJ,Steel JJ .2015 .Benzothiazole and pyrrolone flavivirus inhibitors targeting the viral helicase. ACS Infect Dis, 1(3) : 140-8.
[58] Bhakat S,Delang L,Kaptein S,Neyts J,Leyssen P,Jayaprakash V .2015 .Reaching beyond HIV/HCV: Nelfinavir as a potential starting point for broad-spectrum protease inhibitors against dengue and chikungunya virus. RSC Adv, 5(104) : 85938-49.
[59] Richard AS,Zhang A,Park SJ,Farzan M,Zong M,Choe H M .2015 .Virionassociated phosphatidylethanolamine promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses. Proc Natl Acad Sci USA, 112(47) : 14682-7.
[60] Farias KJS,Machado PRL,Muniz JAPC,Imbeloni AA .2014 .Antiviral activity of chloroquine against dengue virus type 2 replication in Aotus monkeys. Viral Immunol, 28(3) : 161-9.
[61] Carocci M,Hinshaw SM,Rodgers MA,Villareal VA,Burri DJ,Pilankatta R .2015 .The bioactive lipid 4-hydroxyphenyl retinamide inhibits flavivirus replication. Antimicrob Agents Chemother, 59(1) : 14-95.
[62] Basavannacharya C,Vasudevan SG .2014 .Suramin inhibits helicase activity of NS3 protein of Dengue virus in a fluorescence-based high throughput assay format. Biochem Biophys Res Commun, 09(3) : 539-44.
[63] Yang CC,Hu HS,Wu RH,Wu SH,Lee SJ,Jiaang WT .2014 .A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease. Antimicrob Agents Chemother, 58(1) : 13-9.
[64] Varga N,Sutkeviciute I,Ribeiro-Viana R,Berzi A,Ramdasi R,Daghetti A .2014 .A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus. Biomaterials, 01(13) : 4175-84.
[65] Soto-Acosta R,Bautista-Carbajal P,Syed GH,Siddiqui A,Del Angel RM .2014 .Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of Dengue virus. Antiviral Res, 07 : 132-40.
[66] Martinez-Gutierrez M,Correa-Londoño LA,Castellanos JE,Gallego-Gómez JC,Osorio JE .2014 .9(2): e87412. PLoS One, : .
[67] Boonyasuppayakorn S,Reichert ED,Manzano M,Nagarajan K,Padmanabhan R.,Amodiaquine R. .2014 .an antimalarial drug, inhibits dengue virus type 2 replication and infectivity. Antiviral Res, 03 : 125-34.
[68] Cheung YY,Chen KC,Chen H,Seng EK,Chu JJ. H. .2014 .Antiviral activity of lanatoside C against dengue virus infection. Antiviral Res, 09 : 93-9.
[69] Pambudi S,Kawashita N,Phanthanawiboon S,Omokoko MD,Masrinoul P,Yamashita A .2013 .A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication. Biochem Biophys Res Commun, 09(3) : 393-8.
[70] de Wispelaere M,LaCroix AJ,Yang PL .2013 .The small molecules AZD0530 and dasatinib inhibit dengue virus RNA replication via Fyn kinase. J Virol, 87(13) : 13-81.
[71] Ichiyama K,Gopala Reddy SB,Zhang LF,Chin WX,Muschin T,Heinig L . .Sulfated polysaccharide, curdlan sulfate, eficiently prevents entry/fusion and restricts antibody-dependent enhancement of dengue virus infection in vitro: a possible candidate for clinical application. PLoS Negl Trop Dis, 7(4) : .
[72] Ng TC,Teo CH,Toh JY,Dunn AG,Ng CJ,Ang TF .2022 .Factors influencing healthcare seeking in patients with dengue: Systematic review. Trop Med Int Health, 27(1) : 13-27.
[73] Hussain Z,Rani S,Ma F,Li W,Shen W,Gao T .2023 .2): e2425. Rev Med Virol, 33 : .
[74] Xu M,Chang N,Tu T,Sun J,Jiang J,Xia Y .2022 .5): e0010360. PLoS Negl Trop Dis, 16 : .
[75] Tian N,Zheng JX,Guo ZY,Li LH,Xia S,Lv S .2022 .. Trop Med Infect Dis, 7(8) : 1-180.
[76] Foucambert P,Esbrand FD,Zafar S,Panthangi V,Kurupp ARC,Raju A .2022 .9): e28916. Cureus, 14 : .
[77] Oliveira JB,Murari TB,Nascimento Filho AS,Saba H,Moret MA,Cardoso CAL .2022 .Paradox between adequate sanitation and rainfall in dengue fever cases. Sci Total Environ, 860 : 160491.
[78] Das S,Abreu C,Harris M,Shrader J,Sarvepalli S. .2022 .Severe thrombocytopenia associated with dengue fever: an evidencebased approach to management of thrombocytopenia. Case Rep Hematol, : 3358325.
[79] Jing Q,Wang M. .2023 .Progress in Dengue Epidemiology. Progress in China Epidemiology, : 121-37.
[80] Kok BH,Lim HT,Lim CP,Lai NS,Leow CY,Leow CH .2022 .Dengue virus infection - a review of pathogenesis, vaccines, diagnosis and therapy. Virus Res, 324(1) : 199018.
[81] Panda K,Alagarasu K,Patil P,Agrawal M,More A,Kumar NV .2021 .In vitro antiviral activity of α-mangostin against dengue virus serotype-2 (DENV-2). Molecules, 26(10) : 3016.
[82] Clark MJ,Miduturu C,Schmidt AG,Zhu X,Pitts JD,Wang J .2016 .GNF-2 inhibits dengue virus by targeting Abl kinases and the viral E protein. Cell Chem Biol, 03(4) : 443-52.
[83] Dhiman M,Sharma L,Dadhich A,Dhawan P,Sharma M. .2022 .Traditional knowledge to contemporary medication in the treatment of infectious disease dengue: a review. Front Pharmacol, 13 : 750494.
[84] Abd Wahab NZ,Ibrahim N. .2022 .Styrylpyrone derivative (SPD) extracted from Goniothalamus umbrosus binds to dengue virus serotype-2 envelope protein and inhibits early stage of virus replication. Molecules, 27(14) : 4566.
[85] Lee HC,Butler M,Wu SC .2012 .Using recombinant DNA technology for the development of live-attenuated dengue vaccines. Enzyme Microbial Technol, 05(2) : 67-72.
[86] Guy B,Noriega F,Ochiai RL,L'azou M,Delore V,Skipetrova A .2017 .A recombinant live attenuated tetravalent vaccine for the prevention of dengue. Expert Rev Vaccines, 16(7) : 671-84.
[87] Sridhar S,Luedtke A,Langevin E,Zhu M,Bonaparte M,Machabert T .2018 .Efect of dengue serostatus on dengue vaccine safety and eficacy. N Engl J Med, 379(4) : 327-40.
[88] Bajrai LH,Sohrab SS,Alandijany TA,Mobashir M,Reyaz M,Kamal MA .2021 .Gene expression profiling of early acute febrile stage of dengue infection and its comparative analysis with Streptococcus pneumoniae infection. Front Cell Infect Microbiol, 11 : 707905.
[89] Lestari CSW,Handayani S,Novientri G .2023 .Prospect of dengue vaccine development with halal process-based technology. AIP Conf Proc, 2606 : 030002.